The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.

Joel Lebowitz Biography and Net Worth

CFO of Schrödinger

Joel Lebowitz, Executive Vice President and Chief Financial Officer, joined Schrödinger in 2018. Joel has extensive experience in the pharmaceutical industry. In 26 years at Merck, he held finance leadership positions in pharmaceutical R&D portfolio analysis, financial planning and analysis, reporting, financing and investing, business development, project management, and financial evaluation. He holds a BA in Applied Mathematics and Economics from Brown University and an MBA in Finance and International Business from Columbia Graduate School of Business.

What is Joel Lebowitz's net worth?: The estimated net worth of Joel Lebowitz is at least $103,341.96 as of July 14th, 2021. Mr. Lebowitz owns 5,574 shares of Schrödinger stock worth more than $103,342 as of November 17th. This net worth evaluation does not reflect any other assets that Mr. Lebowitz may own. Learn More about Joel Lebowitz's net worth.
How do I contact Joel Lebowitz?: The corporate mailing address for Mr. Lebowitz and other Schrödinger executives is 120 WEST 45TH STREET 17TH FLOOR, NEW YORK NY, 10036. Schrödinger can also be reached via phone at 212-295-5800 and via email at [email protected]. Learn More on Joel Lebowitz's contact information.
Has Joel Lebowitz been buying or selling shares of Schrödinger?: Joel Lebowitz has not been actively trading shares of Schrödinger in the last ninety days. Most recently, Joel Lebowitz sold 5,574 shares of the business's stock in a transaction on Wednesday, July 14th. The shares were sold at an average price of $68.04, for a transaction totalling $379,254.96. Following the completion of the sale, the chief financial officer now directly owns 5,574 shares of the company's stock, valued at $379,254.96. Learn More on Joel Lebowitz's trading history.
Who are Schrödinger's active insiders?: Schrödinger's insider roster includes Robert Abel (Insider), Karen Akinsanya (Insider), Rosana Kapeller-Libermann (Director), Joel Lebowitz (CFO), David Shaw (Major Shareholder), Yvonne Tran (EVP), and Jorg Weiser (Director). Learn More on Schrödinger's active insiders.
Are insiders buying or selling shares of Schrödinger?: During the last twelve months, insiders at the sold shares 5 times. They sold a total of 5,182 shares worth more than $129,616.27. The most recent insider tranaction occured on October, 15th when insider Margaret Dugan sold 1,531 shares worth more than $27,221.18. Insiders at Schrödinger own 8.6% of the company. Learn More about insider trades at Schrödinger.
Information on this page was last updated on 10/15/2024.

Joel Lebowitz Insider Trading History at Schrödinger

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/14/2021	Sell	5,574	$68.04	$379,254.96	5,574
6/14/2021	Sell	5,574	$77.36	$431,204.64	5,574
5/18/2021	Sell	5,574	$64.45	$359,244.30	5,574
4/14/2021	Sell	5,574	$78.43	$437,168.82	5,574
3/15/2021	Sell	5,574	$79.96	$445,697.04	5,574
2/5/2021	Sell	11,259	$99.08	$1,115,541.72	12,374
11/23/2020	Sell	16,722	$64.90	$1,085,257.80	16,722
8/19/2020	Sell	117,051	$67.77	$7,932,546.27	117,051

Joel Lebowitz Buying and Selling Activity at Schrödinger

Schrödinger Company Overview

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Today's Range

Now: $18.54

$18.46

$20.46

50 Day Range

MA: $18.72

$16.98

$22.25

2 Week Range

Now: $18.54

$16.67

$38.00

Volume

1,221,118 shs

Average Volume

876,651 shs

Market Capitalization

$1.35 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.5

Bill Gates’s Next Big AI Bet: Stargate

From Brownstone Research | Ad

In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.

I believe we are about to do it again with this new AI project called Stargate